With so little attention focused on peripheral neuropathy, the leading researchers were assembled to focus on potential solutions. These scientists discovered a novel biological pathway that may reverse peripheral nerve damage. Our company name, WinSanTor, named after the city of each of the founders—Winnipeg, San Diego and Toronto—was incorporated in 2011 to capture the transformative discoveries originally developed and patented at the University of Manitoba, the University of California at San Diego and the University of Toronto. Our research has been funded and supported by the leading stakeholders in the field, including the Juvenile Diabetes Research Foundation, National Institute of Diabetes and Digestive and Kidney Diseases at the National Institutes of Health and the Canadian Institutes of Health Research, initially in response to the lack of treatments, but subsequently because of our results in potentially reversing the damage associated with diabetic neuropathy, and more broadly, peripheral neuropathy.
